UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 12, 2016
Accession Number:
Submission Type:
CIK:
0001621227
Company Name:
Adaptimmune Therapeutics PLC
File Number:
333-212713